Safety and Efficacy of Isomyosamine in Reducing Inflammation and Treating Muscle Loss in Older Adults After Hip or Thigh Bone Fractures

PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 1, 2025

Primary Completion Date

March 1, 2026

Study Completion Date

March 1, 2026

Conditions

Sarcopenia in ElderlyFrailtyFrailty/SarcopeniaFrailty in Older Adults

Interventions

DRUG

Isomyosamine 250mg

Isomyosamine 250 mg capsules dosed 4 times daily

DRUG

Placebo 250 mg

Placebo 250 mg capsule 4 times daily

All Listed Sponsors

lead

TNF Pharmaceuticals, Inc.

INDUSTRY